Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.9M
-
Number of holders
-
161
-
Total 13F shares, excl. options
-
43.6M
-
Shares change
-
+1.72M
-
Total reported value, excl. options
-
$1.36B
-
Value change
-
+$18.5M
-
Put/Call ratio
-
2.33
-
Number of buys
-
80
-
Number of sells
-
-96
-
Price
-
$31.15
Significant Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q1 2018
219 filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share as of Q1 2018.
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) has 161 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.6M shares
of 44.9M outstanding shares and own 97.12% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3.28M shares), BlackRock Inc. (3.23M shares), Consonance Capital Management LP (2.63M shares), HealthCor Management, L.P. (2.3M shares), PointState Capital LP (2.04M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.81M shares), venBio Select Advisor LLC (1.72M shares), Partner Fund Management, L.P. (1.7M shares), MACQUARIE GROUP LTD (1.55M shares), and SCHRODER INVESTMENT MANAGEMENT GROUP (1.23M shares).
This table shows the top 161 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.